The Healthcare Customer You Lose May Never Choose a Competitor.

Almost one-third of US dentists said in the first quarter of 2026 that they were not busy enough and could have treated more patients. CareQuest Institute for Oral Health estimates that about 32 million US adults have dental needs that will exceed their insurance plan’s annual maximum benefit. Among people who reached or exceeded that limit, 46 percent said it prevented them from seeking further treatment.

KFF, formerly the Kaiser Family Foundation, found that 36 percent of US adults had skipped or postponed needed healthcare because of cost in the previous 12 months. Even among insured adults, 37 percent reported going without needed care because of cost.

A patient who walks away from a treatment plan may never appear in a competitor’s market share. The procedure is postponed, reduced, or abandoned. A smaller number of consumers may find a cheaper provider or travel abroad. A provider can retain its position against named rivals while losing consumers who have decided that the category itself has become too expensive to buy.

“Too expensive” can mean very different things

A patient who rejects a $5,000 treatment plan may have reached a hard financial limit. Another may be able to afford the treatment over time but struggle with the amount due immediately. Someone else may have the money and remain unconvinced that the expected result warrants the price.

From the provider’s side, each produces the same outcome: treatment recommended, treatment declined. Yet a discount given to someone who would have paid the existing price gives away margin. Financing will have little effect where the total bill is beyond reach. More persuasive marketing is unlikely to help someone whose household simply cannot absorb the expense.

CareQuest found that among adults who had reached their annual dental insurance maximum, 59 percent of those in households earning below $30,000 said the limit prevented them from receiving further treatment. Even among households earning $100,000 or more, 35 percent said the same.

Income alone cannot explain which customers can be recovered. The more useful distinction is where willingness to proceed collapsed and what changed at that point.

The missing customer contains useful evidence

Healthcare companies generally know far more about people who complete treatment than people who disappear after receiving a diagnosis, recommendation, or estimate. Patient surveys can explain the experience that was delivered, while brand tracking can show which providers people recognize and consider. Neither necessarily explains why someone who wanted care decided not to buy it.

The first task is to establish whether the price actually caused the rejection, rather than treating every unbooked treatment plan as an affordability problem.

Compare patients given similar treatment recommendations and follow what happens after the estimate arrives. Some will proceed. Others will delay, reduce the treatment, or seek another solution.

One patient may begin asking about monthly payments. Another may start looking for a cheaper treatment. Someone else may question whether the procedure is urgent enough to justify the expense. Price has triggered different responses that require different interventions.

Research conducted close to the decision can establish whether the barrier is the total cost, the timing of payment, or the value attached to the treatment. If large numbers of prospects reach consultation and disappear at the same financial threshold, increasing awareness may simply send more customers into the same blockage.

Medical travel shows what happens when the price gap becomes large enough

CareQuest found that 58 percent of US adults who had traveled abroad for dental care cited lower treatment costs as their main reason. Its estimate of 9.6 million Americans refers to adults who report having done so at some point, rather than patients leaving US practices in a single year.

The finding is better read as evidence that some consumers will widen their search when the price difference becomes large enough.

For a US dental practice, Mexico can enter the decision without opening a clinic across the street. Elsewhere in healthcare, consumers may move to a lower-cost setting, choose a different treatment, or wait until the need becomes harder to ignore.

Affordability can be redesigned

Aspen Dental offers a $49 annual savings plan for patients without insurance, with discounts of up to 30 percent on eligible services. This gives an uninsured consumer another route into care without requiring conventional dental coverage.

MDsave takes another approach, with participating providers offering procedures at a single upfront price that can include hospital, physician, anaesthesia, and other common fees. Patients know what they will pay before treatment rather than waiting for separate bills to arrive afterward. More than 1 million people have purchased care through the platform, according to MDsave.

A provider considering a $1,000 discount should know whether the same commercial investment would recover more demand by reducing the amount due immediately, increasing certainty over the final bill, or changing what is included in the price.

Patients facing a realistic treatment decision can be shown different combinations of price and payment structure while the clinical offer remains constant. Their choices reveal whether the headline price must fall or another part of the transaction is preventing purchase.

The trade-offs will also differ by treatment. A procedure costing several thousand dollars will behave differently from routine care, while something perceived as urgent will have a different price threshold from treatment that consumers believe they can postpone.

The commercial test is whether the additional treatment generated by a new price or payment model is worth more than the margin surrendered to produce it.

A high price also forces the customer to judge value

Healthcare is difficult to price because consumers often have limited evidence with which to assess quality before treatment. A large price difference makes that uncertainty more consequential.

A patient comparing domestic dental care with cheaper overseas care may immediately understand the savings. The value of paying more at home is harder to quantify.

Continuity with the treating clinician, easier follow-up, or greater certainty over responsibility if something goes wrong may support a domestic premium only if consumers recognize those advantages and consider them worth paying for. Price-value research can establish which parts of the proposition sustain that premium and where the price gap becomes too large for them to compensate.

A provider may find that follow-up care carries considerable value. It may be found that consumers understand the clinical advantages perfectly well and still choose based on price. Either finding is more useful than investing in benefits that customers will not pay for.

Research should find the demand before it disappears

Affordability research should begin when the customer sees the price and starts weighing whether the treatment is still worth pursuing.

The strongest research follows patients from recommendation to estimate and then to what they actually do, while the decision is still recent enough to be recalled clearly. It compares the offer they saw, the reasons they gave, and the behavior that followed. Any alternative price or payment model should be tested against real choices, with bookings providing the harder test of whether stated intent translates into demand.

The key question is how much lost demand can be recovered without giving away more margin than the additional treatment is worth. The answer determines whether the provider should continue spending to attract more customers, change payment structures, or defend a premium by offering benefits patients are genuinely willing to pay for.

Treatment plans left unbooked, rising requests for financing, or conversion falling sharply above a particular price can appear long before market share moves.

Kadence helps healthcare organizations identify where demand breaks, why customers walk away, and which changes can recover that demand at a commercially viable cost. Before making major decisions, the research should establish which part of the affordability problem either investment can solve.